Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NWS | Ann: Appendix 3C | 09:40 | 0 | 49 | |||
|
|||||||
NWS | Ann: Appendix 3C | 09:38 | 0 | 51 | |||
|
|||||||
NWS | NWS ta | 18/03/24 | 2 | 212 | |||
|
|||||||
NWS | Ann: Appendix 3C | 18/03/24 | 0 | 59 | |||
|
|||||||
NWS | Ann: Appendix 3C | 18/03/24 | 0 | 61 | |||
|
|||||||
NWS | Ann: Notification of cessation of securities - NWS | 18/03/24 | 0 | 79 | |||
|
|||||||
NWS | Ann: Notification of cessation of securities - NWS | 18/03/24 | 0 | 61 | |||
|
|||||||
NWS | Ann: Appendix 3C | 15/03/24 | 0 | 70 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |